HealthTree Logo
search more_vert
App Logo
person Sign In / Create Account
arrow_back TREATMENTS
Bispecific Antibodies (BsAb)
Bispecific antibodies act as a go-between, recognizing and attaching to cancer cells and joining them to the immune system’s T cells. That cancer cell-to-T cell attachment results in the T cells attacking cancer cells.
Talquetamab (Talvey®) VIEW TREATMENT Elranatamab (Elrexfrio™) VIEW TREATMENT Teclistamab (Tecvayli®) VIEW TREATMENT

Get the latest thought leadership on Multiple Myeloma delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Multiple Myeloma Newsletter" for Multiple Myeloma news, life with Multiple Myeloma stories, Multiple Myeloma clinical trials, Multiple Myeloma 101 articles and events with Multiple Myeloma experts.

Thanks to our HealthTree Community for Multiple Myeloma Sponsors:

Janssen Oncology
Adaptive Biotechnologies
Amgen Oncology
Bristol Myers Squibb

Follow Us

facebook instagram twitter youtube